BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15218293)

  • 21. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
    Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
    Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
    Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y
    Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.
    Kochi M; Fujii M; Kaiga T; Takahashi T; Morishita Y; Kobayashi M; Kasakura Y; Takayama T
    Oncology; 2004; 66(6):445-9. PubMed ID: 15452373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
    Ajani JA; Mansfield PF; Janjan N; Morris J; Pisters PW; Lynch PM; Feig B; Myerson R; Nivers R; Cohen DS; Gunderson LL
    J Clin Oncol; 2004 Jul; 22(14):2774-80. PubMed ID: 15254045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
    Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
    Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach.
    Imada T; Rino Y; Takahashi M; Shiozawa M; Hatori S; Noguchi Y; Amano T; Kobayashi O; Sairenji M; Motohashi H
    Anticancer Res; 1998; 18(1A):231-5. PubMed ID: 9568082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
    Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB
    Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study.
    Wang LB; Shen JG; Xu CY; Chen WJ; Song XY; Yuan XM
    Hepatogastroenterology; 2008; 55(86-87):1895-8. PubMed ID: 19102417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.
    Nashimoto A; Yabusaki H; Nakagawa S; Takii Y; Tsuchiya Y; Otsuo T
    Anticancer Res; 2009 Nov; 29(11):4689-96. PubMed ID: 20032421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on neoadjuvant chemotherapy of Borrmann 4 type carcinoma of stomach and its clinical significance].
    Mai M; Ogino T; Ueda H; Ooi A; Takahashi Y; Sawaguchi K; Suga T; Ohta T; Asai T; Itoh T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):586-97. PubMed ID: 2351851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
    Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric carcinoma: curative resection and adjuvant chemotherapy.
    Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
    Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and clinical outcome of proximal-third gastric cancer.
    Sakaguchi T; Watanabe A; Sawada H; Yamada Y; Tatsumi M; Fujimoto H; Emoto K; Nakano H
    J Am Coll Surg; 1998 Oct; 187(4):352-7. PubMed ID: 9783780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of early proximal gastric carcinoma in Chinese diagnosed using WHO criteria.
    Fang C; Huang Q; Lu L; Shi J; Sun Q; Xu GF; Gold J; Mashimo H; Zou XP
    J Dig Dis; 2015 Jun; 16(6):327-36. PubMed ID: 25754397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.